CHRS
Coherus Oncology, Inc. Common Stock
$1.35
3.44%
+0.04
Notify me if price changes either direction
Buy CHRS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
164.4M
Enterprise value
27.0M
Trailing PE
2.4727273
Forward PE
-5.037037
PEG Ratio
0.010115702590909
Enterprise to EBITDA
-0.339
Enterprise to revenue
0.097
Price to book MRQ
1.8013245
Price to sales TTM
0.5918905
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
277.7M
EBITDA
-79791000
Diluted EPS TTM
0.55
Total Cash (MRQ)
191.7M
Current ratio (MRQ)
1.238
Operating Cash Flow (TTM)
-90189000
CHRS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
